Research and Markets (http://www.researchandmarkets.com/research/hh5zvr/countryfocus) has announced the addition of the "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia" report to their offering.
In 2013, the government spent $1 billion on R&D on medical and health science and exported $3.8 billion of pharmaceutical products. The pharmaceutical market in Australia was worth $18 billion in 2008 and is projected to reach $32 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 5.1%. The medical device market was valued at $5.9 billion in 2008 and is projected to grow at a CAGR of 4.9% to $10.4 billion by 2020.
The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by Our team of industry experts.
The population of Australia in 2013 was 23.2 million, having grown at a CAGR of 1.6% from 2008. Medicare is Australia's public health insurance scheme, and provides free or subsidized healthcare services to the Australian population. The government is attempting to reduce the barriers to manufacturing drugs and encourage exports through the introduction of various new policies.
These positive growth trends can be primarily attributed to:
- An increasingly elderly population
- Universal health coverage
- Government initiatives
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Overview of Pharmaceutical and Medical Device Markets
4 Market Access
5 Country Analysis
6 Opportunities and Challenges
7 Appendix
Companies Featured:
- Pfizer
- AstraZeneca
- Novartis
- Sanofi
- Alphapharm
- Siemens Healthcare
- GE Healthcare
- Medtronic
- DePuy Companies
- Hoffmann-La Roche
For more information visit http://www.researchandmarkets.com/research/hh5zvr/countryfocus
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals
